Ultrasonic surgical platform Nexus approved in USAugust 5, 2019
The US FDA has granted approval for Nexus, an ultrasonic surgical platform, Misonix Inc announced.
Nexus combines all the features of Misonix’s existing solutions, including BoneScalpel, SonicOne and Sonastar, into a single fully integrated platform.
The Nexus platform is driven by a new proprietary digital algorithm that results in more power, efficiency and control.
The device uses Smart Technology that allows for easier setup and use besides RF capabilities for use in general surgery procedures.
Physicians will be able to utilize Nexus’ increased power to improve tissue resection rates, in concert with its proprietary digital algorithm to perform more efficient bone removal procedures.